Treatment of Metastatic Colorectal Cancer With Monoclonal Antibody to Vascular Endothelial Growth Factor: Does the Metastatic Site Make the Difference?

In reply:

  • Kabbinavar, Fairooz

  • Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, CA

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The authors indicated no potential conflicts of interest.

Journal of Clinical Oncology 21(18):p 3543, September 15, 2003.
Copyright © 2003 American Society of Clinical Oncology